Ga direct naar de inhoud

Ga direct naar de navigatie

Uitgave van

Archief voor de categorie ‘Overig’

Researchers discover new way of giving people sweet dreams

Today psychologist Professor Richard Wiseman from the University of Hertfordshire announces the results of a two-year study into dream control. The experiment shows that it is now possible for people to create their perfect dream, and so wake up feeling especially happy and refreshed.

Bron: News-Medical.Net Meer lezen »

Data transparency debate: Europe decides its future

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing pharma companies to release their trial information. But whilst these groups have had much public exposure, what have been less visible – but more important for the industry – are new plans for 2014 that […]

Bron: InPharm.com Meer lezen »

An end to animal testing for drug discovery?

As some countries and companies roll out new rules to limit animal testing in pharmaceutical products designed for people, scientists are stepping in with a new way to test therapeutic drug candidates and determine drug safety and drug interactions – without using animals.

Bron: Medical News Today: Pharma Industry/Biotech Industry Meer lezen »

Barriers to Effective Content Marketing: Lessons from Australia

As a content marketer, when I complete a project, I sometimes get this feeling like I’m handing over the keys to a Ferrari, only to watch it crash before getting out of the car park. Looking at the data revealed in Content Marketing in Australia 2014: Benchmarks, Budgets and Trends, I’d say clients are also […]

  Meer lezen »

Onderzoek: meetmysterie in pr ontrafeld

Natuurlijk willen we allemaal weten hoe het nou zit met het meten van pr. En dan vooral hoe pr-bureaus in Nederland hier mee omgaan. Heeft de pr-professional echt de advertentiewaarden bij het oud vuil gezet? Goed, we weten nu wel dat het meten van de output van pr-middelen al lang niet meer alleen aan advertentiewaarden […]

Bron: PMLiVE Meer lezen »

Pharma packaging for the digital future

The way the industry presents brands is changing. Radical changes in the way technology is impacting packaging, unthinkable in the ultra-conservative world of the pharmaceutical industry only a few years ago, are starting to become the norm. Last year Boehringer Ingelheim’s wireless pill bottle was introduced, which measures medication and sends patients reminders in order […]

  Meer lezen »

Co-creatie en crowdsourcing als beïnvloedingsstrategie

Co-creatie en crowdsourcing zijn twee ‘vaktermen’ die regelmatig verwisseld en verward worden. Beide gaan over het betrekken van een groep gebruikers, klanten of lezers bij de creatie van kennis, een product, een dienst of content. Maar eindigt de overeenkomst daar? Geiger et al (2011) heeft het over ‘integrative sourcing without remuneration’ en ‘selective sourcing without crowd […]

  Meer lezen »

Doctors less likely to adjust depressed patients’ blood pressure drugs

Doctors may be less likely to make medication changes for patients with uncontrolled high blood pressure who are also depressed, according to a new study. So-called clinical inertia is when doctors don’t intensify treatment – upping the dose of current drugs or adding new drugs, for instance – for patients who are not at their […]

Bron: Reuters Meer lezen »

Recruitment als marketingtool

Recruitment en marketing hebben veel overeenkomsten. Door deze overeenkomsten beter op elkaar af te stemmen, kan een veel grotere synergie bereikt worden, waarmee veel winst valt te behalen. Zou recruitment eigenlijk een marketingactiviteit moeten zijn? Het klinkt als een zinvol idee, maar (hoe) is het haalbaar?

Bron: marketingfacts.nl Meer lezen »

Breaking into the oncology market

In many ways, the US approval of Boehringer’s Gilotrif for patients with late-stage non-small cell lung cancer (NSCLC) last year was fairly innocuous, given that there are a number of drugs for the disease on the market. But this was not just another approval for Boehringer, as the drug (known as Giotrif in Europe) represents […]

  Meer lezen »

« Oudere artikelen | Nieuwere artikelen »